Bramlett KS - Search Results

1

Prediction of the tissue-specificity of selective estrogen receptor modulators by using a single biochemical method.

Dai SY, Chalmers MJ, Bruning J, Bramlett KS, Osborne HE, Montrose-Rafizadeh C, Barr RJ, Wang Y, Wang M, Burris TP, Dodge JA, Griffin PR. Dai SY, et al. Among authors: bramlett ks. Proc Natl Acad Sci U S A. 2008 May 20;105(20):7171-6. doi: 10.1073/pnas.0710802105. Epub 2008 May 12. Proc Natl Acad Sci U S A. 2008. PMID: 18474858 Free PMC article.

2

Effects of selective estrogen receptor modulators (SERMs) on coactivator nuclear receptor (NR) box binding to estrogen receptors.

Bramlett KS, Burris TP. Bramlett KS, et al. Mol Genet Metab. 2002 Jul;76(3):225-33. doi: 10.1016/s1096-7192(02)00043-4. Mol Genet Metab. 2002. PMID: 12126937

3

Target specificity of selective estrogen receptor modulators within human endometrial cancer cells.

Bramlett KS, Burris TP. Bramlett KS, et al. J Steroid Biochem Mol Biol. 2003 Jul;86(1):27-34. doi: 10.1016/s0960-0760(03)00258-9. J Steroid Biochem Mol Biol. 2003. PMID: 12943742

4

Helix-stabilized cyclic peptides as selective inhibitors of steroid receptor-coactivator interactions.

Leduc AM, Trent JO, Wittliff JL, Bramlett KS, Briggs SL, Chirgadze NY, Wang Y, Burris TP, Spatola AF. Leduc AM, et al. Among authors: bramlett ks. Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11273-8. doi: 10.1073/pnas.1934759100. Epub 2003 Sep 17. Proc Natl Acad Sci U S A. 2003. PMID: 13679575 Free PMC article.

5

Ligands specify coactivator nuclear receptor (NR) box affinity for estrogen receptor subtypes.

Bramlett KS, Wu Y, Burris TP. Bramlett KS, et al. Mol Endocrinol. 2001 Jun;15(6):909-22. doi: 10.1210/mend.15.6.0649. Mol Endocrinol. 2001. PMID: 11376110

6

Reconstitution of functional nuclear receptor proteins using high pressure refolding.

Schoner BE, Bramlett KS, Guo H, Burris TP. Schoner BE, et al. Among authors: bramlett ks. Mol Genet Metab. 2005 Aug;85(4):318-22. doi: 10.1016/j.ymgme.2005.04.012. Mol Genet Metab. 2005. PMID: 15946878

7

The hypolipidemic natural product guggulsterone is a promiscuous steroid receptor ligand.

Burris TP, Montrose C, Houck KA, Osborne HE, Bocchinfuso WP, Yaden BC, Cheng CC, Zink RW, Barr RJ, Hepler CD, Krishnan V, Bullock HA, Burris LL, Galvin RJ, Bramlett K, Stayrook KR. Burris TP, et al. Mol Pharmacol. 2005 Mar;67(3):948-54. doi: 10.1124/mol.104.007054. Epub 2004 Dec 15. Mol Pharmacol. 2005. PMID: 15602004

8

Thioether side chain cyclization for helical peptide formation: inhibitors of estrogen receptor-coactivator interactions.

Galande AK, Bramlett KS, Burris TP, Wittliff JL, Spatola AF. Galande AK, et al. Among authors: bramlett ks. J Pept Res. 2004 Mar;63(3):297-302. doi: 10.1111/j.1399-3011.2004.00152.x. J Pept Res. 2004. PMID: 15049842

9

Ser-884 adjacent to the LXXLL motif of coactivator TRBP defines selectivity for ERs and TRs.

Ko L, Cardona GR, Iwasaki T, Bramlett KS, Burris TP, Chin WW. Ko L, et al. Among authors: bramlett ks. Mol Endocrinol. 2002 Jan;16(1):128-40. doi: 10.1210/mend.16.1.0755. Mol Endocrinol. 2002. PMID: 11773444

10

Potent inhibitors of LXXLL-based protein-protein interactions.

Galande AK, Bramlett KS, Trent JO, Burris TP, Wittliff JL, Spatola AF. Galande AK, et al. Among authors: bramlett ks. Chembiochem. 2005 Nov;6(11):1991-8. doi: 10.1002/cbic.200500083. Chembiochem. 2005. PMID: 16222726

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters